91˿Ƶ

Diamond Therapeutics Signs Agreement with 91˿Ƶ for Research on Low-Dose LSD

Published: 4 February 2021

TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...

Pages

Back to top